BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17020536)

  • 21. pH-dependence and structure-activity relationships in the papain-catalysed hydrolysis of anilides.
    Lowe G; Yuthavong Y
    Biochem J; 1971 Aug; 124(1):117-22. PubMed ID: 5126467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large rate accelerations in antibody catalysis by strategic use of haptenic charge.
    Thorn SN; Daniels RG; Auditor MT; Hilvert D
    Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactive immunization.
    Wirsching P; Ashley JA; Lo CH; Janda KD; Lerner RA
    Science; 1995 Dec; 270(5243):1775-82. PubMed ID: 8525366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyclonal antibody catalytic variability.
    Stephens DB; Thomas RE; Stanton JF; Iverson BL
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):127-34. PubMed ID: 9576860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cocaine catalytic antibodies: the primary importance of linker effects.
    Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD
    Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PAPAIN-CATALYSED HYDROLYSIS OF SOME HIPPURIC ESTERS. A NEW MECHANISM FOR PAPAIN-CATALYSED HYDROLYSIS.
    LOWE G; WILLIAMS A
    Biochem J; 1965 Jul; 96(1):199-204. PubMed ID: 14346990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A catalytic antibody against a tocopherol cyclase inhibitor.
    Manetsch R; Zheng L; Reymond MT; Woggon WD; Reymond JL
    Chemistry; 2004 May; 10(10):2487-506. PubMed ID: 15146522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissection of an antibody-catalyzed reaction.
    Stewart JD; Krebs JF; Siuzdak G; Berdis AJ; Smithrud DB; Benkovic SJ
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7404-9. PubMed ID: 8052597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
    Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
    J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new strategy for the generation of catalytic antibodies.
    Shokat KM; Leumann CJ; Sugasawara R; Schultz PG
    Nature; 1989 Mar; 338(6212):269-71. PubMed ID: 2922053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity.
    Tawfik DS; Zemel RR; Arad-Yellin R; Green BS; Eshhar Z
    Biochemistry; 1990 Oct; 29(42):9916-21. PubMed ID: 2271630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phospholipase A2-like catalytic antibody.
    Isomura S; Ito K; Haruna M
    Bioorg Med Chem Lett; 1999 Feb; 9(4):555-8. PubMed ID: 10098662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The scope of antibody catalysis.
    Jacobsen JR; Schultz PG
    Curr Opin Struct Biol; 1995 Dec; 5(6):818-24. PubMed ID: 8749371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyridoxal-5'-phosphate-dependent catalytic antibodies.
    Gramatikova S; Mouratou B; Stetefeld J; Mehta PK; Christen P
    J Immunol Methods; 2002 Nov; 269(1-2):99-110. PubMed ID: 12379355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactive-site design in folded-polypeptide catalysts--the leaving group pKa of reactive esters sets the stage for cooperativity in nucleophilic and general-acid catalysis.
    Nilsson J; Baltzer L
    Chemistry; 2000 Jun; 6(12):2214-20. PubMed ID: 10926228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transition-state stabilization as a measure of the efficiency of antibody catalysis.
    Stewart JD; Benkovic SJ
    Nature; 1995 Jun; 375(6530):388-91. PubMed ID: 7760931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A catalytic antibody programmed for torsional activation of amide bond hydrolysis.
    Aggarwal R; Benedetti F; Berti F; Buchini S; Colombatti A; Dinon F; Galasso V; Norbedo S
    Chemistry; 2003 Jul; 9(13):3132-42. PubMed ID: 12833295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-Butyl-N-methyl-4-nitrophenyl carbamate as a specific active site titrator of bile-salt-dependent lipases.
    Fourneron JD; Abouakil N; Chaillan C; Lombardo D
    Eur J Biochem; 1991 Mar; 196(2):295-303. PubMed ID: 2007401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triazene drug metabolites. Part 17: Synthesis and plasma hydrolysis of acyloxymethyl carbamate derivatives of antitumour triazenes.
    Carvalho E; Francisco AP; Iley J; Rosa E
    Bioorg Med Chem; 2000 Jul; 8(7):1719-25. PubMed ID: 10976519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody catalysis via strategic use of haptenic charge.
    Kikuchi K; Hilvert D
    Acta Chem Scand (Cph); 1996 Apr; 50(4):333-6. PubMed ID: 8639376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.